Thermomedics, Inc. designs, develops and markets medical diagnostic equipment for professional healthcare providers. Our products are specifically designed for use in a wide range of medical settings, delivering nearly instantaneous diagnostic information. Our goal was simple from the start. We wanted to build the best equipment and bring the most cutting edge technology to frontline medical professionals.
Ease of use... peace of mind

Thermomedics, Inc. is controlled and operated by PositiveID Corporation, a developer of biological detection and diagnostic systems for America's homeland defense and the global healthcare market.

PositiveID specializes in the detection of biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need.


Our Management Team


William J. Caragol

William J. Caragol was appointed Chairman and Chief Executive Officer of PositiveID in 2011, and has served as its President since its inception.  Since September 28, 2012, Mr. Caragol has also been its acting chief financial officer.

Mr. Caragol served as Steel Vault’s chief executive officer and a member of its Board of Directors during 2008 and 2009, when Steel Vault became the company’s wholly-owned subsidiary. Prior to that, Mr. Caragol was the vice president of business development and chief financial officer of Millivision Technologies, a technology company focused on

security applications. Prior to his role at Millivision Technologies, Mr. Caragol was a consulting partner with East Wind Partners LLP, a technology and telecommunications consulting company, in Washington, D.C, and spent eight years at Deloitte and Touche.

He is a member of the American Institute of Certified Public Accountants and graduated from the Washington & Lee University with a bachelor of science in Administration and Accounting.  Mr. Caragol has also served on several boards, both public and private.


Gary O'Hara

Mr. Gary O'Hara is a Founder of Intelligent Medical Systems, Inc. Mr. O'Hara has been the Chief Technology Officer of Sanomedics International Holdings, Inc. since July 28, 2010. He has over 25 years of experience in medical device product innovation and business development. Prior to his work in the medical device industry, he co-founded Tryom, Inc. which was a developer and manufacturer of handheld personal information devices and electronic games of strategy such as backgammon, chess and contract bridge. Mr. O'Hara serves as Member of Advisory Board at Sanomedics International Holdings, Inc. 
He invented the first commercialized infrared

tympanic thermometer (FirstTemp® and Genius® brands) for which he was cited as Inventor of the Year by the San Diego Patent Law Association. Mr. O’Hara has also been active in the seed and startup phases of many ventures through his involvement with the Tech Coast Angels which is an organization of 150 investors that invest in and mentor early stage technology and biomedical companies. Mr. O’Hara holds numerous patents related to medical devices and electronic computer games and holds B.S. and M.S. degrees in Electrical Engineering from the University of Michigan as well as an MBA from Eastern Michigan University.


Ron Benincasa

After receiving his PharmB degree and Post-grad degree in Pharmacology, from St. John's University, he spent time as a Research Scientist at Roche Laboratories, and as a Regulatory Officer for Richardson-Vicks and Wyeth Labs.

Ron then crossed over to Product Management, Marketing Development and Sales Management roles in companies such as American Home Products, BioMedical Sciences, ERIKA Dialysis, Graphic Stress Corporation, and US Medical Instruments.

Ron was a co-inventor of the world's first Tympanic Thermometer while at Intelligent Medical Systems, where he served in executive sales and marketing positions and ultimately managed the sale of that $40M company to American Home Products. He has repeatedly served as CEO of start-up and early-stage healthcare companies, with direct responsibility for the sales planning and management functions in addition to his leadership role.